SARS-CoV spike glycoprotein

Also Known As:

spike glycoprotein, SARS-CoV; S protein, SARS-CoV; S protein, severe acute respiratory syndrome coronavirus; SARS S protein, SARS-CoV; SARS-CoV spike protein,; spike glycoprotein, SARS-coronavirus

Networked: 18 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Membrane Proteins: 10078
    - Membrane Fusion Proteins: 5
      - Viral Fusion Proteins: 34
        Coronavirus Spike Glycoprotein: 25
        SARS-CoV spike glycoprotein: 18
  - Viral Proteins: 4250
    - Viral Structural Proteins: 171
      - Viral Envelope Proteins: 291
        Viral Fusion Proteins: 34
        Coronavirus Spike Glycoprotein: 25
        SARS-CoV spike glycoprotein: 18

Experts

1.	Alpan, Oral: 2 articles (01/2021 - 10/2020)
2.	Arditi, Moshe: 2 articles (01/2021 - 10/2020)
3.	Bukhari, Zaheer: 2 articles (01/2021 - 10/2020)
4.	Coatney, Paige: 2 articles (01/2021 - 10/2020)
5.	Dogan, Mikail: 2 articles (01/2021 - 10/2020)
6.	Gupta, Raavi: 2 articles (01/2021 - 10/2020)
7.	Hardy, Rachel: 2 articles (01/2021 - 10/2020)
8.	Hayes, Chelsea: 2 articles (01/2021 - 10/2020)
9.	Klapper, Ellen: 2 articles (01/2021 - 10/2020)
10.	Kleinberg, Michael: 2 articles (01/2021 - 10/2020)

Related Diseases

1.	Infections 01/15/2008 - "Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection." 10/01/2010 - "Here, we extended our previous study to ACE2 molecules from seven additional bat species and tested their interactions with human SARS-CoV spike protein using both HIV-based pseudotype and live SARS-CoV infection assays. " 09/01/2005 - "Our results showed that all of the immunized animals generated humoral immunity against the SARS-CoV spike protein, and the sera of immunized rats showed strong capable of protecting from SARS-CoV infection in vitro. " 06/01/2011 - "Furthermore, NL63-CoV RBD inhibits hACE2-dependent transduction by SARS-CoV spike protein, a successful application of the hot spot theory that has the potential to become a new antiviral strategy against SARS-CoV infections. " 11/01/2008 - "Here we show, by focusing on a dominant neutralization epitope, that contemporaneous- and cross-strain nAb responses against SARS-CoV spike protein exist during natural infection. "
2.	COVID-19 01/01/2021 - "Interestingly, some COVID-19 patients also possessed NAbs against SARS-CoV Spike protein pseudovirus. " 10/14/2020 - "Interestingly, some COVID-19 patients also possessed NAbs against SARS-CoV Spike protein pseudovirus. " 01/01/2021 - "Keywords: SARS-CoV; spike protein; nucleocapsid; COVID-19; interferon."
3.	Lung Injury 01/01/2010 - "It was shown that recombinant SARS-CoV spike protein (SARS-S) downregulates ACE2 expression and thereby promotes lung injury. "
4.	Virus Diseases (Viral Diseases) 01/21/2005 - "Analysis of SARS-CoV spike glycoprotein (S) using recombinant plasmid and virus infections demonstrated that the S-precursor (proS) exists as a approximately 190 kDa endoplasmic reticulum form and a approximately 210 kDa Golgi-modified form. "
5.	Lymphoma (Lymphomas) 10/01/2010 - "We transduced SARS-CoV spike protein-displayed recombinant baculovirus (SSDRB), vAtEpGS688, into peripheral B cells and B lymphoma cells. "

Related Drugs and Biologics

1.	Antibodies
2.	Biomarkers (Surrogate Marker)
3.	Vaccines
4.	Peptides (Polypeptides)
5.	Interferons
6.	Glycoproteins (Glycoprotein)
7.	Antiviral Agents (Antivirals)
8.	Epitopes
9.	Amino Acids
10.	polyacrylamide

Related Therapies and Procedures

1.	Intranasal Administration